Dr. David Scott, is an Associate Professor in the Department of Medicine at the University of British Columbia and a Scientist in the Department of Lymphoid Cancer Research (BC Cancer). He gained his MBChB, PhD from the University of Auckland, New Zealand. Following his clinical fellowships in hematology, he took up a post-doctoral fellowship at BC Cancer with Drs. Gascoyne and Connors. In 2014, he was appointed as a Clinician-Scientist at BC Cancer, receiving the inaugural BC Cancer Foundation Clinical Investigator Award. Dr. Scott’s research focusses on unravelling the determinants of treatment failure in B-cell lymphoid cancers (lymphoma and CLL) and translating this knowledge into assays to guide treatment management. He has authored over 60 peer-reviewed papers, has been an invited speaker at many conferences and receives research funding from Genome Canada, the Terry Fox Research Institute, the Lymphoma Research Foundation and the National Institutes of Health. He is the Clinical Director of BC Cancer’s Center for Lymphoid Cancer, a member of the Lymphoma/Leukemia Molecular Profiling Project and the Translational Sciences Co-Chair of the Lymphoma Tumor Group of ECOG.